• Demonstrate their commitment to members with a serious oradvanced illness
  • Assess their programs for palliative care
  • Evaluate the value that they bring to your customers
  • Determine the effectiveness of their focus on deliveringquality care while balancing cost

Escalating costs for payers

will quadruple5 percent of beneficiaries in their last year ofliferecent study

  • 48.7 percent (nearly half) of older Medicarebeneficiaries were classified as “high persistent,” maintaininghigh spending throughout the year;
  • 10.2 percent showed a “progressive” pattern,starting low but increasing steeply;
  • 29.0 percent of decedents were “moderatepersistent,” mimicking the “high persistent” pattern except for aspending dip a few months prior to death;
  • 12.1 percent of the sample exhibited a“late rise” in the final four months of life after very lowspending in the earlier months of that finalyear.

Palliative care benefits payers and members

NewEngland Journal of Medicinenearly threemonths longerNational Center forBiotechnology Information

  • Focuses on care coordination across all settings
  • Emphasizes ongoing support at home
  • Ensures advance care planning
  • Engages physicians and other care providers
  • Provides integrated, dedicated, interdisciplinary, team-basedcare
  • Establishes goals of care
  • Addresses needs of those who are ineligible or those who refusehospice
  • Identifies gaps in care
  • Provides pain and symptom relief
  • Facilitates disease understanding and self-management
  • Offers psycho-social support
  • Primary and secondary diagnoses
  • Medical and hospitalization/ED history
  • Functional status and activities of daily living
  • Symptom assessment
  • Medication review; adherence assessment
  • Adequacy of home, family, safety and financial supports
  • Patient's understanding of illness
  • Goals of care/Advance Care Planning
  • Services in place or needed
  • Patient risk evaluation
  • Palliative Plan of Care

Advance care planning

  • Getting information on the types of life-sustaining treatmentsthat are available.
  • Deciding what types of treatment one would or would not want ifdiagnosed with a life-limiting illness.
  • Sharing one's personal values with loved ones.
  • Completing advance directives to put into writing what types oftreatment one would or would not want should one be unable to speakfor oneself.

Source:https://www.nhpco.org/advance-care-planning

Value of a specialized solution

focus on comfort and quality of life

Innovate and differentiate services

Greer Myers is President, Turn-Key Health and EVP, ChiefDevelopment Officer, Enclara Pharmacia. With more than 20 years ofhealth care experience, he joined Enclara Healthcare in 2014, andmaintains dual roles as its President of Turn-Key Health and itsExecutive Vice President of Corporate Development of EnclaraPharmacia. Bringing strengths in post-acute operations, mergers andacquisitions, pharmacy benefits management, strategy and businessdevelopment, he also has strong vertical experience in payer,provider and healthcare IT verticals.

Continue Reading for Free

Register and gain access to:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.